LUCI DAVID P 4
4 · Acurx Pharmaceuticals, Inc. · Filed Nov 22, 2021
Insider Transaction Report
Form 4
LUCI DAVID P
DirectorPresident and CEO10% Owner
Transactions
- Purchase
Common Stock
2021-11-19$4.80/sh+5,200$24,960→ 1,008,723 total
Holdings
- 15,083(indirect: By Spouse)
Common Stock
- 35,000(indirect: By Children)
Common Stock